Oxurion NV (OXUR.BR)

EUR 0.27

(0.0%)

Total Liabilities Summary of Oxurion NV

  • Oxurion NV's latest annual total liabilities in 2023 was 19.73 Million EUR , up 19.06% from previous year.
  • Oxurion NV's latest quarterly total liabilities in 2024 Q2 was 19.36 Million EUR , down 0.0% from previous quarter.
  • Oxurion NV reported annual total liabilities of 16.57 Million EUR in 2022, down -17.05% from previous year.
  • Oxurion NV reported annual total liabilities of 19.98 Million EUR in 2021, up 116.37% from previous year.
  • Oxurion NV reported quarterly total liabilities of 19.73 Million EUR for 2023 FY, up 19.06% from previous quarter.
  • Oxurion NV reported quarterly total liabilities of 19.73 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Oxurion NV (2023 - 2006)

Historical Annual Total Liabilities of Oxurion NV (2023 - 2006)

Year Total Liabilities Total Liabilities Growth
2023 19.73 Million EUR 19.06%
2022 16.57 Million EUR -17.05%
2021 19.98 Million EUR 116.37%
2020 9.23 Million EUR -21.22%
2019 11.72 Million EUR 22.71%
2018 9.55 Million EUR -44.06%
2017 17.08 Million EUR 45.03%
2016 11.77 Million EUR 31.87%
2015 8.93 Million EUR -29.69%
2014 12.7 Million EUR 2.58%
2013 12.38 Million EUR 10.5%
2012 11.2 Million EUR 1.31%
2011 11.06 Million EUR 132.99%
2010 4.74 Million EUR -36.72%
2009 7.5 Million EUR 55.95%
2008 4.81 Million EUR 35.04%
2007 3.56 Million EUR 73.25%
2006 2.05 Million EUR 0.0%

Peer Total Liabilities Comparison of Oxurion NV

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -185.532%
ABIVAX Société Anonyme 131.05 Million EUR 84.94%
Adocia SA 31.87 Million EUR 38.073%
Aelis Farma SA 13.08 Million EUR -50.887%
Biophytis S.A. 15.84 Million EUR -24.525%
Advicenne S.A. 24.37 Million EUR 19.038%
genOway Société anonyme 14.45 Million EUR -36.491%
IntegraGen SA 5.97 Million EUR -230.045%
Medesis Pharma S.A. 6.42 Million EUR -207.119%
Neovacs S.A. 3.71 Million EUR -431.663%
NFL Biosciences SA 3.62 Million EUR -445.091%
Plant Advanced Technologies SA 6.78 Million EUR -190.991%
Quantum Genomics Société Anonyme 3.31 Million EUR -496.235%
Sensorion SA 13.22 Million EUR -49.207%
Theranexus Société Anonyme 5.01 Million EUR -293.446%
TME Pharma N.V. 2.78 Million EUR -608.654%
Valbiotis SA 13.7 Million EUR -43.974%
TheraVet SA 1.48 Million EUR -1229.03%
Valerio Therapeutics Société anonyme 20.46 Million EUR 3.576%
argenx SE 402.79 Million EUR 95.1%
BioSenic S.A. 32.26 Million EUR 38.83%
Celyad Oncology SA 9.97 Million EUR -97.795%
DBV Technologies S.A. 38.74 Million USD 49.062%
Galapagos NV 1.56 Billion EUR 98.736%
Genfit S.A. 105.92 Million EUR 81.367%
GeNeuro SA 20.13 Million EUR 2.005%
Hyloris Pharmaceuticals SA 8.61 Million EUR -129.169%
Innate Pharma S.A. 132.29 Million EUR 85.081%
Inventiva S.A. 101.59 Million EUR 80.573%
MaaT Pharma SA 22.46 Million EUR 12.148%
MedinCell S.A. 77.77 Million EUR 74.623%
Nanobiotix S.A. 95.74 Million EUR 79.386%
Onward Medical N.V. 25.69 Million EUR 23.2%
Oryzon Genomics S.A. 25.12 Million EUR 21.45%
OSE Immunotherapeutics SA 59.07 Million EUR 66.594%
Pharming Group N.V. 228.28 Million EUR 91.355%
Poxel S.A. 53.9 Million EUR 63.385%
GenSight Biologics S.A. 34.72 Million EUR 43.168%
Transgene SA 26.51 Million EUR 25.572%
Financière de Tubize SA 123.65 Million EUR 84.039%
UCB SA 6.56 Billion EUR 99.699%
Valneva SE 341.14 Million EUR 94.215%
Vivoryon Therapeutics N.V. 4.54 Million EUR -334.044%